PMV Pharma, Chiromics to develop new cancer and infectious disease therapeutics
Under the deal, PMV Pharma will have a non-exclusive license to use Chiromics’ chemical compound library and a screening collaboration to discover and optimize new small molecules against
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.